VAN NOSTRAND ROBERT L

SEC source: 0001104659-26-002511 · tm262627-6_4seq1.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,900

F1 · shares: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0001104659-25-059166 · tm2517920-1_4seq1.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,400

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 10

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,951 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit (each, a "Company RSU") represented a contingent right to receive one Company Share.

F6 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each Company RSU that was then outstanding as of immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company RSU immediately prior to the Effective Time and (ii) the Merger Consideration. Notwithstanding the foregoing, in the case of each Company RSU granted in 2025, the Merger Consideration will instead be payable at the time the original Company RSU would have vested, subject to accelerated vesting in certain circumstances.

F6 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each Company RSU that was then outstanding as of immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company RSU immediately prior to the Effective Time and (ii) the Merger Consideration. Notwithstanding the foregoing, in the case of each Company RSU granted in 2025, the Merger Consideration will instead be payable at the time the original Company RSU would have vested, subject to accelerated vesting in certain circumstances.

F7 · derivative.expiration_date: Not applicable.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 9

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,322 shares

Expires 2034-06-13

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 8

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,009 shares

Expires 2033-06-22

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 7

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,757 shares

Expires 2032-06-08

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 6

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2031-06-20

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 5

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2030-05-26

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 4

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2028-06-17

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 3

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2026-06-13

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2025-06-15

F3 · price: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · price: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

F3 · derivative.exercise_date: Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a "Company Option") that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.

F4 · derivative.exercise_date: (Continued from Footnote 3) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Consideration was canceled for no consideration.

SEC source: 0000950170-25-049636 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2025 (the "Merger Agreement"), by and among Intra-Cellular Therapies, Inc. (the "Company"), Johnson & Johnson, a New Jersey corporation ("Parent"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, subject to the terms and conditions thereof, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, effective as of April 2, 2025 (the "Effective Time").

F2 · kind: (Continued from Footnote 1) At the Effective Time, each share of common stock, par value $0.0001 per share, of the Company ("Company Shares") issued and outstanding immediately prior to the Effective Time (other than certain Company Shares canceled pursuant to the Merger Agreement and Company Shares with respect to which appraisal rights had been properly and validly exercised) was automatically converted into the right to receive an amount equal to $132.00 per share in cash (the "Merger Consideration"), without interest thereon and less any applicable tax withholdings.

F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2025 (the "Merger Agreement"), by and among Intra-Cellular Therapies, Inc. (the "Company"), Johnson & Johnson, a New Jersey corporation ("Parent"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which, subject to the terms and conditions thereof, Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, effective as of April 2, 2025 (the "Effective Time").

F2 · price: (Continued from Footnote 1) At the Effective Time, each share of common stock, par value $0.0001 per share, of the Company ("Company Shares") issued and outstanding immediately prior to the Effective Time (other than certain Company Shares canceled pursuant to the Merger Agreement and Company Shares with respect to which appraisal rights had been properly and validly exercised) was automatically converted into the right to receive an amount equal to $132.00 per share in cash (the "Merger Consideration"), without interest thereon and less any applicable tax withholdings.

SEC source: 0001104659-25-003497 · tm253166-4_4seq1.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Common Stock · 18,500 shares

Expires 2035-01-10

F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0001104659-25-003497 · tm253166-4_4seq1.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,900

F1 · shares: The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0000950170-24-080987 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,340

SEC source: 0000950170-24-077472 · ownership.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,567 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: On June 23, 2023, the reporting person was granted 1,567 restricted stock units, which vested on the first anniversary of the grant date (June 23, 2024).

F2 · derivative.expiration_date: On June 23, 2023, the reporting person was granted 1,567 restricted stock units, which vested on the first anniversary of the grant date (June 23, 2024).

SEC source: 0000950170-24-077472 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock.

SEC source: 0000950170-24-076380 · ownership.xml · derivative · entry 4

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option was granted on June 30, 2014 and will expire on June 30, 2024. All shares underlying this option have vested.

SEC source: 0000950170-24-076380 · ownership.xml · nonDerivative · entry 3

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,690

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.01 to $76.09, inclusive. The reporting person undertakes to provide to the Issuer, any secuirty holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0000950170-24-076380 · ownership.xml · nonDerivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,799

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $76.00, inclusive. The reporting person undertakes to provide to the Issuer, any secuirty holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0000950170-24-076380 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,690

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On June 18, 2024, the reporting person exercised options to purchase 20,000 shares of common stock that are expiring on June 30, 2024.

SEC source: 0000950170-24-075077 · ownership.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,322

Underlying: Common Stock · 4,322 shares

Expires 2034-06-13

SEC source: 0000950170-24-075077 · ownership.xml · derivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,951

Underlying: Common Stock · 2,951 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: On June 14, 2024, the reporting person was granted 2,951 restricted stock units, vesting on the first anniversary of the grant date (June 14, 2025).

F2 · derivative.expiration_date: On June 14, 2024, the reporting person was granted 2,951 restricted stock units, vesting on the first anniversary of the grant date (June 14, 2025).

SEC source: 0000950170-24-040166 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,690

SEC source: 0001628280-24-013923 · wk-form4_1711986710.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,635

F1 · ownership.direct: Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the first quarter of 2024.

SEC source: 0000950170-24-022485 · ownership.xml · derivative · entry 4

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option was granted on March 21, 2014 and will expire on March 21, 2024. All shares underlying this option have vested.

SEC source: 0000950170-24-022485 · ownership.xml · nonDerivative · entry 3

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,611

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.0026 to $73.42, inclusive. The reporting person undertakes to provide to the Issuer, any secuirty holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0000950170-24-022485 · ownership.xml · nonDerivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,960

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.0016 to $73.00, inclusive. The reporting person undertakes to provide to the Issuer, any secuirty holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0000950170-24-022485 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-006381 · tm243935-6_4seq1.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-22

F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0001104659-24-006381 · tm243935-6_4seq1.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,400

F1 · shares: The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0000950170-24-001303 · ownership.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,611

SEC source: 0001628280-24-000210 · wk-form4_1704317714.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,711

F1 · ownership.direct: Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the fourth quarter of 2023.

SEC source: 0001209191-23-051143 · doc4.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,535

SEC source: 0001121702-23-000056 · wk-form4_1696275701.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,832

F1 · shares: Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the third quarter of 2023.

SEC source: 0001628280-23-024201 · wk-form4_1688577858.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,964

F1 · shares: Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the second quarter of 2023.

SEC source: 0001209191-23-041084 · doc4.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,430

SEC source: 0001209191-23-039930 · doc4.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,009

Underlying: Common Stock · 7,009 shares

Expires 2033-06-22

SEC source: 0001209191-23-039930 · doc4.xml · derivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,567

Underlying: Common Stock · 1,567 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: On June 23, 2023, the reporting person was granted 1,567 restricted stock units, vesting on the first anniversary of the grant date (June 23, 2024).

F2 · derivative.expiration_date: On June 23, 2023, the reporting person was granted 1,567 restricted stock units, vesting on the first anniversary of the grant date (June 23, 2024).

SEC source: 0001628280-23-020149 · wk-form4_1685479171.xml · derivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-05-25

F1 · derivative.exercise_date: These options will vest and become exercisable in equal quarterly installments over 4 years from 5/25/2023, beginning on 8/25/2023 and ending on 5/25/2027.

F2 · derivative.underlying_shares: These options were granted to the Reporting Person as the annual option grant to non-employee directors pursuant to the Issuer's Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors.

SEC source: 0001209191-23-024899 · doc4.xml · derivative · entry 3

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2029-06-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All shares underlying this option have vested.

SEC source: 0001209191-23-024899 · doc4.xml · nonDerivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,345

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.

SEC source: 0001209191-23-024899 · doc4.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,345

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-23-010704 · wf-form4_168064347214024.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,924

F1 · shares: Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the first quarter of 2023.

SEC source: 0001209191-23-022799 · doc4.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,345

SEC source: 0001104659-23-010623 · tm235353d3_4seq1.xml · derivative · entry 2

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Common Stock · 9,500 shares

Expires 2033-02-02

F2 · derivative.exercise_date: The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0001104659-23-010623 · tm235353d3_4seq1.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,400

F1 · shares: The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

SEC source: 0001225198-23-000003 · wf-form4_167286575293917.xml · derivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,109

Underlying: Common Stock · 2,109 shares

Expires 2032-12-31

F1 · shares: These options were granted to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $3,333 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the fourth quarter of 2022.

SEC source: 0001209191-23-000197 · doc4.xml · nonDerivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,250

SEC source: 0001225198-22-000002 · wf-form4_166482853690997.xml · derivative · entry 1

VAN NOSTRAND ROBERT L · CIK 0001225198 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,601

Underlying: Common Stock · 1,601 shares

Expires 2032-09-30

F1 · shares: These options were granted to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the third quarter of 2022.